Pizzirusso A, Oliva P, Maione S, D'Amico M, Rossi F, Berrino L
Institute of Pharmacology and Toxicology, Faculty of Medicine and Surgery, 2nd University of Naples, Italy.
Naunyn Schmiedebergs Arch Pharmacol. 1998 May;357(5):514-8. doi: 10.1007/pl00005201.
In order to evaluate the role played by vasopressin on pressor responses elicited by stimulation of the periaqueductal gray (PAG) area by excitatory amino acids we carried out in vivo studies in genetically vasopressin deficient rats (Brattleboro). Microinjections of 1-glutamic acid (glutamate, 0.6 to 60 nmol/rat) or N-methyl-d-aspartic acid (NMDA, 0.07 to 7 nmol/rat) into the PAG area of freely moving Brattleboro rats induced increases of arterial blood pressure values significantly lower than those obtained in Long Evans rats (control) (glutamate in Brattleboro rats: from +2+/-1 mmHg to 16+/-3 mmHg; glutamate in Long Evans rats: from +16+/-2 mmHg to +36+/-4 mmHg; NMDA in Brattleboro rats: from +5+/-2 mmHg to +34 +/-8 mmHg; NMDA in Long Evans rats: from +18+/-7 mmHg to 80+/-9 mmHg; n=5). Similarly, in anaesthetized Brattleboro rats (urethane 1.2 g/kg i.p.) pressor responses to NMDA microinjections (0.7 nmol/rat) into the PAG area were significantly lower than in Long Evans rats (controls) (+15+/-3 mmHg vs +24+/-4 mmHg). In Long Evans rats NMDA injection also reversed blood pressure decrease induced by ganglionic blocker, hexamethonium and/or losartan (3 mg/kg i.v.), an AT1 receptor antagonist. In Brattleboro rats, NMDA injection did not reverse blood pressure decreases induced by hexamethonium (5 mg/kg i.v.). Moreover, hexamethonium induced blood pressure decrease was not reversed by acetylcholine injection (137 nmol/rat) into the PAG area of anaesthetized Long Evans rats, but if injected before hexamethonium, acetylcholine was able to increase blood pressure (+25+/-3 mmHg). Our results document: i) the importance of the PAG area in the control of cardiovascular system; ii) the involvement of excitatory amino acids in the neural control of vasopressin release; iii) the close relationship between glutamate and vasopressin in the central blood pressure regulation.
为了评估血管升压素在兴奋性氨基酸刺激导水管周围灰质(PAG)区域所引发的升压反应中所起的作用,我们对遗传性血管升压素缺乏大鼠(布拉特洛维大鼠)进行了体内研究。将1-谷氨酸(谷氨酸,0.6至60 nmol/只大鼠)或N-甲基-D-天冬氨酸(NMDA,0.07至7 nmol/只大鼠)微量注射到自由活动的布拉特洛维大鼠的PAG区域,所诱导的动脉血压值升高显著低于在朗-埃文斯大鼠(对照)中所获得的值(布拉特洛维大鼠中的谷氨酸:从+2±1 mmHg升至16±3 mmHg;朗-埃文斯大鼠中的谷氨酸:从+16±2 mmHg升至+36±4 mmHg;布拉特洛维大鼠中的NMDA:从+5±2 mmHg升至+34±8 mmHg;朗-埃文斯大鼠中的NMDA:从+18±7 mmHg升至80±9 mmHg;n = 5)。同样,在麻醉的布拉特洛维大鼠(腹腔注射1.2 g/kg乌拉坦)中,向PAG区域微量注射NMDA(0.7 nmol/只大鼠)所引发的升压反应显著低于朗-埃文斯大鼠(对照)(+15±3 mmHg对+24±4 mmHg)。在朗-埃文斯大鼠中,注射NMDA还可逆转神经节阻滞剂六甲铵和/或AT1受体拮抗剂氯沙坦(静脉注射3 mg/kg)所诱导的血压下降。在布拉特洛维大鼠中,注射NMDA不能逆转六甲铵(静脉注射5 mg/kg)所诱导的血压下降。此外,在麻醉的朗-埃文斯大鼠的PAG区域注射乙酰胆碱(137 nmol/只大鼠)不能逆转六甲铵所诱导的血压下降,但如果在六甲铵之前注射,乙酰胆碱能够升高血压(+25±3 mmHg)。我们的结果表明:i)PAG区域在心血管系统控制中的重要性;ii)兴奋性氨基酸参与血管升压素释放的神经控制;iii)谷氨酸与血管升压素在中枢血压调节中的密切关系。